hybrid compounds (NCI)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehybrid compounds (NCI)
Drug Alias Namehybrid of NSAID, HNO releasing agents and nitroxide (NCI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationDiabetes MellitusCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes MellitusCardiovascular Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A